Results 21 to 30 of about 1,154,067 (288)

Interferon Alpha Association with Neuromyelitis Optica

open access: yesClinical and Developmental Immunology, 2013
Interferon-alpha (IFN-α) has immunoregulatory functions in autoimmune inflammatory diseases. The goal of this study was to determine occurrence and clinical consequences of IFN-α in neuromyelitis optica (NMO) patients.
Nasrin Asgari   +5 more
doaj   +1 more source

The sustained virologic response of nonresponder hepatitis C virus patients with retreatment

open access: yesIndian Journal of Pathology and Microbiology, 2011
Background: Pegylated interferon and ribavirin combination therapy remain the first-line treatment for chronic hepatitis C virus (HCV) infection. In contrast to the large number of studies in treatment-naive patients, the effectiveness of retreatment in ...
Sila Cetin Akhan   +2 more
doaj   +1 more source

Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection

open access: yesActa Dermato-Venereologica, 2023
Mycosis fungoides and Sézary syndrome are rare and largely incurable types of cutaneous T-cell lymphoma with limited therapeutic options. In 1984 Bunn et al.
Janika Gosmann   +4 more
doaj   +1 more source

Bunyaviruses and the type I interferon system [PDF]

open access: yes, 2009
The family Bunyaviridae contains more than 350 viruses that are distributed throughout the world. Most members of the family are transmitted by arthopods, and several cause disease in man, domesticated animals and crop plants. Despite being recognized as
Richard M. Elliott   +7 more
core   +1 more source

Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin. [PDF]

open access: yesEgyptian Journal of Medical Research, 2020
Background: Chronic Hepatitis C is common problem worldwide treated by combination of interferon alpha and ribavirin. Retinopathy is one of the side effects of interferon therapy.
Mansour Hassan   +3 more
doaj   +1 more source

Acute Hepatitis Induced by Alpha-Interferon in a Patient with Chronic Hepatitis C

open access: yesCanadian Journal of Gastroenterology, 2001
Hepatic adverse effects occur very rarely with alpha-interferon therapy. A case of acute hepatitis induced by alpha-interferon in a 33-year-old man with chronic hepatitis C is described.
Ivan Kraus, Dinko Vitezic
doaj   +1 more source

New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C

open access: yesAnnals of Hepatology, 2005
A major challenge in the field of hepatology is the fight against hepatitis C that affects more than 150 million people world-wide. Despite the enormous improvement that has been achieved in the therapy of chronic hepatitis C over the last decade, there ...
Markus Cornberg, Michael P. Manns
doaj   +1 more source

THE IMMUNOCOMPETENT CELLS RECEPTORS RESEARCH UNDER EXPERIMENTAL INFLUENZA INFECTION IN VITRO

open access: yesИнфекция и иммунитет, 2015
Introduction. It is known that interferon is a cytokine and is a substantial part of the immune system necessary for antigenic challenge immune response full expression. Also it is considered that every antigen is an interferon inducer.
A. N. Lisakov   +6 more
doaj   +1 more source

Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression [PDF]

open access: yes, 2005
Type 1 interferons (IFN-?/?) are key mediators of innate antiviral responses but havelittle effect on established replication of dengue viruses, which are mosquito-borneflaviviruses of immense global health importance.
Jones, M   +9 more
core   +1 more source

Тhe prophylactic efficacy of a recombinant interferon alfa-2b drug in children with bronchial asthma

open access: yesДетские инфекции (Москва), 2019
A prospective cohort study was conducted to assess the effect of a recombinant interferon alpha-2b prophylactic course on cyto-immunological parameters of induced sputum in children with mild asthma, the main trigger of exacerbation of which was ...
Y. I. Zhakov   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy